In the aglepristone + prostaglandin group, reduced concentration of circulating albumin (hypoalbuminemia) was observed at onset of treatment, which indicates the concomitant presence of an inflammatory and infectious process, triggering a negative influence of cytokines on hepatic synthesis [28]. This evidence concerns the gene ALB and Hypoalbuminemia.